BR9813637A - Compostos e métodos para a detecção e prevençãode infecção por t. cruzi - Google Patents
Compostos e métodos para a detecção e prevençãode infecção por t. cruziInfo
- Publication number
- BR9813637A BR9813637A BR9813637-2A BR9813637A BR9813637A BR 9813637 A BR9813637 A BR 9813637A BR 9813637 A BR9813637 A BR 9813637A BR 9813637 A BR9813637 A BR 9813637A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- infection
- cruzi
- prevention
- detection
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 208000015181 infectious disease Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 241000223109 Trypanosoma cruzi Species 0.000 abstract 5
- 206010001935 American trypanosomiasis Diseases 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 208000024699 Chagas disease Diseases 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/993,674 US6228372B1 (en) | 1997-04-15 | 1997-12-18 | Compounds and methods for the detection and prevention of T. cruzi infection |
| PCT/US1998/025871 WO1999031246A1 (en) | 1997-12-18 | 1998-12-04 | Compounds and methods for the detection and prevention of t. cruzi infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9813637A true BR9813637A (pt) | 2001-12-04 |
Family
ID=25539818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9813637-2A BR9813637A (pt) | 1997-12-18 | 1998-12-04 | Compostos e métodos para a detecção e prevençãode infecção por t. cruzi |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6228372B1 (https=) |
| EP (1) | EP1038000A1 (https=) |
| JP (1) | JP2002508506A (https=) |
| AR (1) | AR014132A1 (https=) |
| AU (1) | AU1805799A (https=) |
| BR (1) | BR9813637A (https=) |
| CO (1) | CO4820439A1 (https=) |
| WO (1) | WO1999031246A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6375955B1 (en) * | 1995-09-22 | 2002-04-23 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| US6419933B1 (en) | 1995-11-14 | 2002-07-16 | Corixa Corporation | Compounds and methods for the detection and prevention of T.cruzi infection |
| US6228372B1 (en) | 1997-04-15 | 2001-05-08 | Corixa Corporation | Compounds and methods for the detection and prevention of T. cruzi infection |
| EP1945248A4 (en) * | 2005-11-03 | 2008-12-31 | Inbios Internat Inc | Compositions and methods for the detection of trypanosoma cruzi infection |
| US7749717B2 (en) * | 2006-10-19 | 2010-07-06 | Abbott Laboratories | Methods for the detection and diagnosis of Trypanosoma cruzi infection |
| CA3023900A1 (en) * | 2007-12-27 | 2009-07-09 | Abbott Laboratories | Anti-t. cruzi antibodies and methods of use |
| EP2291394B1 (en) | 2008-07-03 | 2017-03-15 | Infectious Disease Research Institute | Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| WO2016071393A1 (en) * | 2014-11-06 | 2016-05-12 | Roche Diagnostics Gmbh | Recombinant trypanosoma cruzi jl7 antigen variants and their use for detecting chagas disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4870006A (en) | 1986-07-24 | 1989-09-26 | Codon | Antigenic material for a chagas' disease detection system |
| WO1990002564A1 (en) | 1988-09-12 | 1990-03-22 | Codon | Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi |
| BR9006039A (pt) | 1990-11-28 | 1992-07-14 | Fundacao Oswaldo Cruz | Processo para preparacao de antigeno conjugado a atividade enzimatica,composicao a base de conjugado enzima-antigeno para utilizacao em diagnostico imunologico e kits de diagnostico imunologico da doenca de chagas a base da dita composicao,para aplicacao individual e/ou em inqueritos epidemiologicos |
| US5304371A (en) | 1992-02-14 | 1994-04-19 | Lasys Corporation | Peptide for diagnosing and immunizing against T. cruzi infection |
| TW246717B (https=) | 1992-07-10 | 1995-05-01 | Abbott Lab | |
| US5756662A (en) | 1995-03-14 | 1998-05-26 | Corixa Corporation | Compounds and methods for the detection of T. cruzi infection |
| US5916572A (en) | 1995-11-14 | 1999-06-29 | Corixa Corporation | Compounds and methods for the detection and prevention of T. cruzi infection |
| US6228372B1 (en) | 1997-04-15 | 2001-05-08 | Corixa Corporation | Compounds and methods for the detection and prevention of T. cruzi infection |
-
1997
- 1997-12-18 US US08/993,674 patent/US6228372B1/en not_active Expired - Lifetime
-
1998
- 1998-12-04 WO PCT/US1998/025871 patent/WO1999031246A1/en not_active Ceased
- 1998-12-04 EP EP98962923A patent/EP1038000A1/en not_active Withdrawn
- 1998-12-04 AU AU18057/99A patent/AU1805799A/en not_active Abandoned
- 1998-12-04 BR BR9813637-2A patent/BR9813637A/pt not_active IP Right Cessation
- 1998-12-04 JP JP2000539145A patent/JP2002508506A/ja active Pending
- 1998-12-17 AR ARP980106437A patent/AR014132A1/es not_active Application Discontinuation
- 1998-12-18 CO CO98075441A patent/CO4820439A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR014132A1 (es) | 2001-02-07 |
| AU1805799A (en) | 1999-07-05 |
| EP1038000A1 (en) | 2000-09-27 |
| WO1999031246A1 (en) | 1999-06-24 |
| CO4820439A1 (es) | 1999-07-28 |
| US6228372B1 (en) | 2001-05-08 |
| JP2002508506A (ja) | 2002-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1996029605A3 (en) | Compounds and methods for the dectection of t. cruzi infection | |
| NO975598L (no) | Monoklonale ape-antistoffer som er spesifikke for primatiserte humane B7.1- og/eller B7.2-former, samt farmasöytiske sammensetninger | |
| BR9611455A (pt) | Compostos e métodos para a detecção e prevenção de infecção por t. cruzi. | |
| ATE161577T1 (de) | Erythropoietin (epo)-peptide und dagegen gerichtete antikörper | |
| PT824699E (pt) | Compostos e metodos para o diagnostico da leishmaniose | |
| BR9610262A (pt) | Compostos e métodos para a imunoterapia e diagnose de tuberculose | |
| ES2113882T3 (es) | Vacuna oral que comprende un antigeno asociado superficialmente con eritrocitos. | |
| FI913560A7 (fi) | Synteettiset peptidit, erikoisesti HCV:n vasta-aineiden havaitsemiseen, HCV infektion diagnoosiin ja sen estämiseen rokotteina | |
| ATE272113T1 (de) | Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma | |
| BRPI0413495A (pt) | reagentes de peptìdeos especìficos para prìons e seus usos | |
| PT807178E (pt) | Proteinas de micobacterias, microrganismos que as produzem e suas utilizacoes vacinicas e para a deteccao da tuberculose | |
| BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
| AU3245000A (en) | Compounds and methods for the detection and prevention of (t. cruzi) infection | |
| BR0113213A (pt) | Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo | |
| BR9813637A (pt) | Compostos e métodos para a detecção e prevençãode infecção por t. cruzi | |
| ES2118939T3 (es) | Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi. | |
| MX24890A (es) | Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene. | |
| ATE118351T1 (de) | Wirkung von hormonen. | |
| DK0882132T3 (da) | Et kombineret humant cytomegalovirus-antigen og anvendelse heraf | |
| FI900272A0 (fi) | Ventilkonstruktion foer en saeck eller motsvarande som skall fyllas med luft. | |
| BR9911601A (pt) | Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores | |
| BR0009077A (pt) | Antìgenos de tuberculose e métodos de uso dos mesmos | |
| ES2308850T3 (es) | Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. | |
| DE69028561D1 (de) | Immunoassay zum Nachweis von Antikörpern gegen HIV | |
| IT8920953V0 (it) | Chiusura di sicurezza in particolare per flaconi di medicinali o simili. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007. |